Neumirna raises €20m, will begin clinical trials for its epilepsy drug

Neumirna’s NMT.001 is built upon FutureNeuro’s foundational work in RNA therapies.

Read more: Neumirna raises €20m, will begin clinical trials for its epilepsy drug